Bold Health Cognitive Behavior Therapy App for IBS Competes with Headspace

London-based digital health company Bold Health is developing digital therapeutics for gastro...

Depiction of a person suffering from Irritable Bowel Syndrome (IBS). The typical symptoms of IBS have been shown. Also, an abnormal colon contraction has been. Photo credit: Myupchar, Wikimedia Commons

London-based digital health company Bold Health is developing digital therapeutics for gastrointestinal conditions. The company is backing a new University of Pennsylvania-led study that will directly compare the company's cognitive behavior therapy (CBT) app for irritable bowel syndrome (IBS) to Headspace's consumer mindfulness and meditation app, reports MobiHealthNews.

Researchers will be randomly assigning 300 participants with IBS to receive either Bold Health's Zemedy app or the Headspace mindfulness app for free. Each group will have the app for eight weeks, after which those who received the Headspace app will also be given access to Zemedy.

Read more: Sanofi and Babylon Team Up to Tackle Digestive Health Issues

Chronic digestive problems are common and often connected to poor mental wellbeing. Through Bold Health’s digital applications, patients get access to cognitive behavioral therapy (CBT) programs designed for their specific condition.

Zemedy’s 6-week program is designed around core cognitive behavioral therapy (CBT) principles. IBS symptoms are often exacerbated due to stress and anxiety.

The aim of the Zemedy program is to help users target symptoms and difficult emotions by changing the surrounding thoughts and behaviors. Users can practice these techniques in their own safe spaces and learn how to manage their symptoms in the long term.

After eight weeks of the trial, the researchers will administer a battery of questionnaires, and those who switched from Headspace to Zemedy will receive a third slew of questions after an additional eight weeks with Bold Health's app, the MobiHealthNews report said.

Through these surveys, the researchers will be comparing responses regarding the study's primary outcomes: IBS quality of life, and the severity of their gastrointestinal symptoms. Secondary outcomes include respondents' scores on various gastrointestinal-related measurements, including their anxiety regarding visceral gut sensations, fear of food or eating, and impairments to their work due to health conditions.

Read more: Oshi Health Launches First All-in-One Mobile App to Allow IBD Patients Manage Their Conditions

With this new trial, Bold Health is making the case that Zemedy, which is branded as a digital therapeutic, will be demonstrably more effective than a corresponding consumer wellness app.

Sam Draper
December 30, 2020

Innovation of the month

Do you want to discover more, visit the website
Vist webiste

Other news

YKK’s Smart Zipper Can Be Connected to Mobile Phones

Described as one of history’s greatest inventions, a zipper not only makes it more convenient to...

5 Best Smart Jewelry Pieces with Hidden Features

The world of wearable technology is moving rapidly. The most embellishing form of the wearable...

Nerivio’s Ren Method Found To Be Effective For Treating Migraine In Randomized Controlled Trials

Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for...

Samsung Leaker Cracks Samsung’s Secret Language Code About Upcoming Galaxy Watch

Last week, Max Weinbach of Android Police found references to Samsung’s next TWS called...
Discover more